Patients Google a FIB-4 calculator, get a number, and still do not know what to do.

A fib-4 score (also searched as fib4 score) is a triage tool — not a diagnosis, not a biopsy, and not a reason to treat yourself. This guide explains what FIB-4 is, how it fits a MASLD fibrosis-risk playbook, when elastography liver testing often comes next, and why an MD should own interpretation.

Educational only. A webpage is not a fibrosis diagnosis. If you want a physician’s input, start with a free 30-minute discovery call with Sorrell MD to interpret labs and map the next step. Telemedicine depends on your state, so check coverage before booking.

Primary playbook theme: American Family Physician (AFP) 2026 — Ohri S, Waterman E, Quiñones AR. Metabolic Dysfunction–Associated Steatotic Liver Disease: Diagnosis and Management. Am Fam Physician. 2026;113(6):578-585. AFP describes two-step noninvasive testing: risk-stratify with the Fibrosis-4 index, then secondary assessment with vibration-controlled transient elastography or ultrasound-based methods for indeterminate or high-risk FIB-4 scores. Numeric adult cutoffs below are playbook-aligned triage themes drawn from concordant pathways AFP sits alongside (including AASLD-aligned education and 2024–2026 primary-care/GI pathway summaries). If your clinician’s source differs, follow your clinician. Do not self-triage from this page alone.

What is a FIB-4 score?

Plain-English definition

What is a FIB-4 score? FIB-4 (Fibrosis-4 index) is a non-invasive estimate of advanced fibrosis risk that combines age and routine blood values. It helps clinicians decide who may stay in primary metabolic follow-up and who needs further testing. It does not replace clinical judgment or specialty evaluation when indicated.

What inputs are used

The standard FIB-4 formula uses:

  • Age
  • AST (aspartate aminotransferase)
  • ALT (alanine aminotransferase)
  • Platelet count

Conceptually: age × AST, divided by (platelet count × square root of ALT). Online calculators apply that formula. The math is simple. The medicine is not.

What FIB-4 is not

  • Not a liver biopsy
  • Not a full metabolic workup
  • Not a license to start GLP-1s, peptides, or “liver detox” protocols at home
  • Not a substitute for elastography, imaging, or hepatology when the clinical picture demands more

FIB-4 calculator searches — useful tool, incomplete care

Why online calculators spike intent

A fib-4 calculator answers curiosity fast. Elevated ALT, an ultrasound that says “fatty liver,” or a friend with MASH can push someone to calculate tonight. That intent is understandable.

Risks of acting on a raw score alone

Raw scores miss context: recent illness, alcohol use, other liver diseases, medications, age extremes, and discordant symptoms. Acting on a screenshot can delay needed specialty care — or create false reassurance.

How clinicians use low / indeterminate / high ranges

AFP 2026 frames screening with FIB-4 for patients at higher risk of advanced fibrosis, then elastography-type secondary testing when FIB-4 is indeterminate or high-risk.

Playbook-aligned triage themes (qualitative only — not for self-triage; thresholds may differ from your clinician’s pathway):

  • Lower-risk results: advanced fibrosis is less likely; many patients remain in primary or metabolic follow-up with periodic reassessment based on overall metabolic risk. Bring labs to a physician — do not close the case yourself.
  • Age matters: pathways adjust how FIB-4 is interpreted in older adults; FIB-4 can also be less reliable in younger adults, where alternative assessment may be needed.
  • Indeterminate or higher-risk results: secondary noninvasive testing (elastography and/or ELF) and/or specialty input are typically considered.

Exact numeric cutoffs belong with a verified clinical source and your clinician — not a blog post. Do not self-triage from any webpage.

FIB-4 first, then elastography liver testing

Playbook logic: start simple, escalate thoughtfully

AFP’s MASLD management article emphasizes sequential noninvasive testing: FIB-4 first, then secondary risk assessment with vibration-controlled transient elastography (VCTE) or ultrasound-based methods when FIB-4 is indeterminate or high-risk. That sequence avoids jumping straight to invasive testing for every fatty-liver label — and avoids ignoring risk when blood scores climb.

What elastography adds

Elastography estimates liver stiffness. Higher stiffness suggests higher fibrosis risk; it is still not histology. When VCTE is unavailable, enhanced liver fibrosis (ELF) blood testing is sometimes used as an alternative secondary tool in pathway summaries.

After an elevated FIB-4 screen, elastography results are interpreted in bands that suggest lower versus higher risk for clinically significant fibrosis — and higher-risk bands often prompt further evaluation or hepatology referral. Exact stiffness thresholds vary by pathway and device context. Bring results to a physician rather than self-sorting.

When imaging / specialty referral still wins

Refer or escalate when scores and clinical concern diverge, cirrhosis is suspected, decompensation signs appear, alternate diagnoses are possible, or MASH specialty therapeutics and biopsy decisions need GI/hepatology. See also Beyond the Scale: Semaglutide, ESSENCE, and MASH for metabolic/GLP-1 context and when Sorrell MD is not a GI substitute.

Urgent care / ER: confusion, vomiting blood, black stools, severe abdominal pain, or sudden jaundice need emergency evaluation — not a calculator or a discovery call.

How FIB-4 connects to MASLD, MASH, and metabolic health

Context link to MASH / MASLD education

MASLD is the umbrella metabolic fatty-liver spectrum. MASH is the inflammatory steatohepatitis subset. Fibrosis stage drives much of long-term liver-related risk. FIB-4 helps triage that risk before elastography — it does not rename your disease from a blog.

Insulin resistance, cardiometabolic risk, and longevity

People with diabetes, obesity, and multiple metabolic risk factors deserve fibrosis-risk literacy as part of cardiometabolic care. Cardiovascular prevention and liver-risk triage often travel together. For the insulin-resistance pattern that can sit behind a normal fasting glucose, see Insulin resistance — a silent epidemic.

Why deep labs beat a single ratio when building a plan

FIB-4 uses four inputs. A Direct MD plan may review 100–200+ biomarkers — glucose, lipids, inflammation, hormones, body composition context — so the next step is not “one ratio forever.” Function Health Labs 2×/year apply on the Longevity Program only; Hormone-program labs are ordered as clinically appropriate and billed separately.

How to calculate FIB-4 — education without DIY medicine

Formula curiosity, answered carefully

How to calculate fib 4 score: use age, AST, ALT, and platelets in the standard FIB-4 equation (or a reputable calculator). Exact interpretation cutoffs should follow a verified clinical source and clinician review — including the AFP 2026 playbook theme and concordant pathway thresholds discussed above.

Bring your labs to a physician

Do not use this article as a diagnose-yourself widget. Print or download your lab PDF. Book time with a licensed clinician. Ask: Does my FIB-4 suggest elastography? Do I need GI referral? What else on my panel changes the plan?

How Sorrell MD uses fibrosis-risk literacy in Direct MD care

Luke Sorrell MD FACP — ABIM internist; A4M Longevity Medicine Fellowship (June 2026); Peptavo Certified Clinician — interprets labs in metabolic context and orders appropriate next steps where licensed. Direct MD — never a PA. Monthly visits and unlimited messaging on programs. Telemedicine: Texas and most other U.S. states (contact the practice to confirm your state). Decisions are case by case when licensed and evaluation is appropriate — not a blanket telemedicine guarantee.

Program fees (labs and meds separate unless stated): Hormone / Body Composition / Metabolic & Peptides $250/mo; Longevity à la carte $375/mo; Longevity $7,500/yr. Gut Optimization and Cardiovascular Risk on site. Direct-pay; HSA/FSA; superbills.

Next step: a free 30-minute discovery call to interpret labs and map FIB-4 → elastography / referral when needed.

Closing

FIB-4 first is a triage habit, not a hobby diagnosis. Calculate curiosity is fine. Clinical ownership belongs with a physician who can order elastography, refer when needed, and place the score inside metabolic care.

Book a free 30-minute discovery call:

Book a free 30-minute call with Dr. Sorrell · Sorrell MD

Related: Semaglutide, ESSENCE, and MASH · Comprehensive Longevity Program · Hormone / Body Composition / Metabolic · Cardiovascular Risk Assessment · Evidence and Safety · About

Frequently asked questions

What is a FIB-4 score?

FIB-4 is a non-invasive estimate of fibrosis risk using age, AST, ALT, and platelet count. It helps triage who may need further testing — it does not replace clinical judgment or specialty evaluation when indicated.

How do I use a FIB-4 calculator?

Calculators apply the FIB-4 formula to lab values. Treat the output as a conversation starter with a physician, not a self-diagnosis.

How do I calculate a FIB-4 score?

The standard formula uses age, AST, ALT, and platelets. Exact interpretation cutoffs should follow a verified clinical source (AFP 2026 MASLD playbook themes and concordant pathways) and clinician review.

What comes after a high or indeterminate FIB-4?

Often further non-invasive assessment such as elastography and/or specialty input — depending on the full clinical picture. AFP describes secondary risk assessment with VCTE or ultrasound-based methods for indeterminate or high-risk FIB-4 scores.

Is elastography the same as FIB-4?

No. FIB-4 is a blood-based risk score. Elastography estimates liver stiffness with imaging/vibration techniques. They sit at different steps of a triage pathway.

Can Sorrell MD interpret my labs and advise next steps?

Yes — via Direct MD telemedicine where licensed. Book a free 30-minute discovery call to discuss labs, MASLD risk framing, and whether additional testing or referral is appropriate. Confirm state license. Not a GI clinic substitute.